Company intelligence / Profile preview

Wanke Pharmaceutical

Baoding, Hebei, China

Ownership: Private
Development stage: Other

Overview

Wanke Pharmaceutical is a specialized pharmaceutical company that is a leading global manufacturer of anti-thyroid medications and active pharmaceutical ingredients (APIs). The company is one of the largest producers of Methimazole and Carbimazole, maintaining international GMP standards and supplying endocrine treatments to global markets.

Therapeutic areas: Endocrinology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Wanke Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wanke Pharmaceutical.

Explore the full profile